Gan & Lee 甘李药业
26 significant filings since 29 May 2026: 17 on equity incentive, 3 on buyback and 2 on pledge released, and 3 other kinds. The latest, on 27 Aug 2026: 关于公司持股5%以上股东部分股份解押的公告.
自 29 May 2026 起有 26 份重大公告：equity incentive 17 份、buyback 3 份、pledge released 2 份，另有 3 类。最新一份（27 Aug 2026）：关于公司持股5%以上股东部分股份解押的公告。
Price History 价格走势
1 session 个交易日, Thu 24 Sep 2026 · Live one-minute prices · High 最高 ¥75.94 · Low 最低 ¥73.34 · −1.50% on the previous close of ¥74.56| FY2026 | FY2027 | |
|---|---|---|
| Now 当前 | 2 brokers | 2 brokers |
| 7 days ago | 2 brokers | 2 brokers |
| 30 days ago | 2.33 | 2.84 |
| 60 days ago | 2.33 | 2.84 |
| 90 days ago | 2.33 | 2.84 |
Consensus is the median of each broker's latest forecast from the 120 days before each date. With fewer than 3 brokers, the broker count is shown. 一致预期为各券商在该日期前 120 天内最新预测的中位数；不足 3 家时显示券商数。
Consensus moved from 2.44 in Jan 2025 to 2.33 in Jul 2026 (-4.5%). 一致预期从 Jan 2025 的 2.44 变为 Jul 2026 的 2.33 (-4.5%)。 The shaded band runs from the lowest to the highest broker forecast.
| FY2026 | FY2027 | |
|---|---|---|
| Last 30 days | ▲ 0 ▼ 0 = 1 | ▲ 0 ▼ 0 = 1 |
| Last 90 days | ▲ 0 ▼ 0 = 2 | ▲ 0 ▼ 0 = 2 |
Each broker's latest forecast is compared with its previous forecast for the same year. A move within 0.5% counts as unchanged. 每家券商的最新预测与其对同一年度的上一次预测比较，变动在 0.5% 以内视为不变。
A surprise needs at least 3 brokers forecasting in the 120 days before the filing. FY2025 had 0 and FY2024 had 2.